We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$4.05B
AUM Growth
+$375M
Cap. Flow
+$164M
Cap. Flow %
4.05%
Top 10 Hldgs %
45.11%
Holding
463
New
50
Increased
205
Reduced
169
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.3%
2 Technology 14.03%
3 Healthcare 5.35%
4 Financials 4.48%
5 Communication Services 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
426
Agilent Technologies
A
$44.5B
$222K 0.01%
1,729
-28
-2% -$3.38K
TGTX icon
427
TG Therapeutics
TGTX
$8.53B
$220K 0.01%
6,100
ET icon
428
Energy Transfer Partners
ET
$73.6B
$220K 0.01%
12,831
+317
+3% +$5.56K
SOLV icon
429
Solventum
SOLV
$15.5B
$220K 0.01%
3,009
EA
430
DELISTED
Electronic Arts
EA
$219K 0.01%
+1,085
New +$180K
AIG icon
431
American International
AIG
$40.1B
$215K 0.01%
2,741
+27
+1% +$2.16K
HOLX
432
DELISTED
Hologic
HOLX
$214K 0.01%
3,176
-5
-0.2% -$332
ODFL icon
433
Old Dominion Freight Line
ODFL
$41.5B
$209K 0.01%
1,482
+31
+2% +$4.75K
KBE icon
434
State Street SPDR S&P Bank ETF
KBE
$1.69B
$207K 0.01%
+3,484
New +$205K
HCA icon
435
HCA Healthcare
HCA
$90.8B
$207K 0.01%
+485
New +$188K
INVA icon
436
Innoviva
INVA
$1.51B
$207K 0.01%
11,324
MDLZ icon
437
Mondelez International
MDLZ
$79.7B
$203K 0.01%
3,253
-72
-2% -$4.64K
ADSK icon
438
Autodesk
ADSK
$57.1B
$203K 0.01%
638
-177
-22% -$53.9K
ZTS icon
439
Zoetis
ZTS
$31B
$202K 0.01%
1,379
-30
-2% -$4.54K
ADMA icon
440
ADMA Biologics
ADMA
$2.12B
$200K ﹤0.01%
13,674
FOLD
441
DELISTED
Amicus Therapeutics
FOLD
$192K ﹤0.01%
24,383
+456
+2% +$3.25K
F icon
442
Ford
F
$55.6B
$154K ﹤0.01%
12,866
+20
+0.2% +$230
IBRX icon
443
ImmunityBio
IBRX
$8.9B
$144K ﹤0.01%
58,436
DMRC icon
444
Digimarc Corp
DMRC
$140M
$130K ﹤0.01%
13,271
UROY
445
Uranium Royalty Corp
UROY
$1.65B
$129K ﹤0.01%
30,000
IOVA icon
446
Iovance Biotherapeutics
IOVA
$3.74B
$94.1K ﹤0.01%
43,345
+5,506
+15% +$13K
BCG
447
Binah Capital Group
BCG
$24.7M
$57.6K ﹤0.01%
+33,482
New +$65.5K
IRWD icon
448
Ironwood Pharmaceuticals
IRWD
$701M
$53.7K ﹤0.01%
40,994
RCKT icon
449
Rocket Pharmaceuticals
RCKT
$397M
$50.2K ﹤0.01%
+15,411
New +$48.5K
RBBN icon
450
Ribbon Communications
RBBN
$358M
$38.1K ﹤0.01%
10,030

Similar funds

Grimes & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Grimes & Company held 463 positions worth $4.05B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $164M of net new capital in Q3 2025, opening 50 new positions and adding to 205 existing holdings. Its largest new stake was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Short-Term National Muni Bond ETF, an estimated $57.9M trimmed.

  • Grimes & Company's largest Q3 2025 buy was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.
  • Grimes & Company added most to Vanguard Morningstar Small-Cap ETF in Q3 2025, an estimated $123M increase.
  • Grimes & Company's biggest Q3 2025 reduction was iShares Short-Term National Muni Bond ETF, cutting an estimated $57.9M.
  • Grimes & Company fully exited Avantis US Small Cap Value ETF in Q3 2025, selling an estimated $443K.
  • Grimes & Company's ten largest holdings make up 45% of its $4.05B portfolio in Q3 2025.
  • Grimes & Company opened 50 new positions and closed 13 in Q3 2025.
  • Grimes & Company's portfolio value rose 10% quarter-over-quarter to $4.05B.

Based on Grimes & Company's 13F filing for Q3 2025, filed 27 Oct 2025.